Preferred Label : elvitegravir;
MeSH note : an HIV-1 integrase inhibitor; structure in first source;
CISMeF synonym : JTK-303;
MeSH hyponym : GS9137; GS-9137; GS 9137; JTK303; JTK 303;
Is substance : O;
UNII : 4GDQ854U53;
Origin ID : C509700;
UMLS CUI : C2606637;
ATC code(s)
Currated CISMeF NLP mapping
MeSH indexing information
MeSH term(s) associated for indexing
Pharmacological action(s)
Record concept(s)
See also inter- (CISMeF)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT
http://www.has-sante.fr/portail/jcms/c_2621468/fr/genvoya
http://www.has-sante.fr/portail/jcms/c_2621468/fr/genvoya-emtricitabine-cobicistat-elvitegravir-et-tenofovir-alafenamide-association-d-antiviraux
2016
false
false
false
France
French
treatment outcome
drug combinations
tenofovir alafenamide
elvitegravir
hiv infections
anti-hiv agents
adult
adolescent
human immunodeficiency virus i infection
administration, oral
HIV integrase inhibitors
reverse transcriptase inhibitors
emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat
Cobicistat
Emtricitabine
evaluation of the transparency committee
guidelines for drug use
tenofovir alafenamide
elvitegravir
adenine
adenine
quinolones
---
https://www.ema.europa.eu/medicines/human/EPAR/Genvoya
2015
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug combinations
drug approval
europe
tenofovir alafenamide
tenofovir alafenamide
elvitegravir
elvitegravir
hiv infections
drug interactions
pregnancy
breast feeding
product surveillance, postmarketing
drug evaluation, preclinical
anti-hiv agents
anti-hiv agents
adult
adolescent
human immunodeficiency virus i infection
administration, oral
Substance with integrase strand transfer inhibitor mechanism of action (substance)
HIV integrase inhibitors
HIV integrase inhibitors
Cytochrome P-450 CYP3A Inhibitors
Cytochrome P-450 CYP3A Inhibitors
reverse transcriptase inhibitors
reverse transcriptase inhibitors
emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat
Cobicistat
Cobicistat
Emtricitabine
Emtricitabine
tenofovir alafenamide
tenofovir alafenamide
elvitegravir
elvitegravir
adenine
adenine
adenine
quinolones
quinolones
---
https://www.ema.europa.eu/medicines/human/EPAR/Vitekta
2013
false
United Kingdom
French
English
elvitegravir
elvitegravir
elvitegravir
elvitegravir
elvitegravir
administration, oral
tablets
product surveillance, postmarketing
drug therapy, combination
adult
hiv infections
HIV-1
drug interactions
pregnancy
breast feeding
HIV integrase inhibitors
HIV integrase inhibitors
drug approval
europe
treatment outcome
drug evaluation, preclinical
summary of product characteristics
package leaflet
quinolones
quinolones
syndication feed
---